Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: October 2023

MissionIRNewsBreaks — Longeveron Inc. (NASDAQ: LGVN; LGVNR) Closes on $4M Registered Direct Offering

Posted on October 16, 2023 by MissionIR

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as hypoplastic left heart syndrome (“HLHS”), Alzheimer’s disease and Aging-Related Frailty, closed on its previously announced registered direct offering. The offering was comprised of … Continue reading →

Posted in Longeveron Inc. LGVN | Leave a comment

Clene Inc. (NASDAQ: CLNN) Applies Patented Nanotechnology to Development of CNM-Au8(R), its Investigational Drug for ALS

Posted on October 16, 2023 by MissionIR

October 2023 has turned into a month for the celebration of nanotechnology. On Wednesday, Oct. 4, 2023, three U.S.-based scientists, Moungi Bawendi, Louis Brus, and Aleksey Ekimov, were awarded the 2023 Nobel Prize in Chemistry for their discovery and synthesis … Continue reading →

Posted in Clene Inc. CLNN | Leave a comment

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Ongoing Diabetes Study Program to Examine its Patented DehydraTECH(TM) Technology with Launch of Human and Animal Studies for Oral GLP-1 Drugs

Posted on October 16, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced its intention to launch new human and animal studies that will explore its patented DehydraTECH(TM) technology on glucagon-like peptide-1 (“GLP-1”) drugs for improved bioavailability, cost-effectiveness, tolerability, weight … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Inks Global Collaboration, License Agreement with SulfoSyn

Posted on October 13, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has granted a new global, exclusive license to SulfoSyn Limited; the license is for the exclusive global use of all nonpharmaceutical applications of Lexaria’s proprietary DehydraTECH-sulforaphane, including the right … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Adds Two K5 ASR Contracts to Growing List of Clients

Posted on October 13, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is continuing to add to its list of valued clients. The company has secured two more contracts for its K5 ASR, including a hotel in … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Featured in Latest Release from The Watchlist by The Market Herald

Posted on October 13, 2023 by MissionIR

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF), a company that is advancing the next generation of nickel-sulphide projects, was in the spotlight during a recent interview released by The Watchlist by The Market Herald. During the interview, The Watchlist’s Ryan Dhillon … Continue reading →

Posted in Canada Nickel Company Inc. CNIKF | Leave a comment

SenesTech Inc. (NASDAQ: SNES) Eager to Work with Cities to Address Rat Crises Using Effective Fertility-Restricting Method

Posted on October 13, 2023 by MissionIR

Once threatened by the sudden COVID-induced closure of businesses and restaurants, which forced rats to adapt by moving to residential areas in search of food or die – renowned rodentologist Bobby Corrigan estimates that hundreds of thousands, if not millions, … Continue reading →

Posted in SenesTech Inc. SNES | Leave a comment

MissionIRNewsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Launch of OPKO Health Inc. (NASDAQ: OPK)-Branded Online Storefront

Posted on October 12, 2023 by MissionIR

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that, through a new e-commerce distribution agreement, it will enable the online sales of OPKO Health Europe, a subsidiary of OPKO Health (NASDAQ: OPK) products in China. Under the agreement … Continue reading →

Posted in NextPlat Corp. NXPL | Leave a comment

MissionIRNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) K5 ASRs and K1B Emergency Communications Systems Deployed for New and Existing Customers

Posted on October 12, 2023 by MissionIR

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, announced two new sales for its K5 ASRs and an expansion sale from an existing user of its K1B line of emergency communication … Continue reading →

Posted in Knightscope Inc. KSCP | Leave a comment

MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Portfolio Expansion to 37 Granted Patents

Posted on October 12, 2023 by MissionIR

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it has been granted two new patents by the Canadian Intellectual Property Office (“CIPO”), increasing its portfolio to 37 granted patents. According to the update, … Continue reading →

Posted in Lexaria Bioscience Corp. LEXX | Leave a comment